Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-14
2005-06-14
Jones, Dwayne C. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S319000
Reexamination Certificate
active
06906064
ABSTRACT:
This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an inhibitor of human epidermal growth factor receptor tyrosine kinase and a cGMP-specific phosphodiesterase inhibitor.
REFERENCES:
patent: 5948779 (1999-09-01), Sperl et al.
Stein, J. H., Editor-in-Chief, Internal Medicine, Fourth Edition, Chapters 71 and 72, 1994.
Ciardiello, F, “Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents”, DRUGS, 60 Suppl 1, 25-32, 2000.
Barker et al. .2001, Bioorganic and Medicinal Chemistry Letters 14:1911-1914.
Chan et al. 2002, Cancer Res. 62:122-128.
Ciardello et al. 2001, Cancer Res. 7:1459-1465.
Moasser et al. 2001, Cancer Res. 61:17184-7188.
Moulder et al. 2001, Cancer Res. 61:8887-8895.
Piazza et al. 1995, Cancer Research 55:3110-3116.
Piazza et al. 1997, Cancer Research 57:2452-2459.
Ranson et al. 2002, J. Clin Oncology 20:2240-2250.
Thompson et al. 1995, Journal of the National Cancer Institute 87:1259-1260.
Alila Hector W.
Thompson W. Joseph
Jones Dwayne C.
Lee Shu M.
Stewart Alexander
LandOfFree
Method for treating a patient with neoplasia using Iressa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating a patient with neoplasia using Iressa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating a patient with neoplasia using Iressa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3495913